← back to search

Marcello Dallio

AbbVie (United States) · US
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Medicine, Cirrhosis, Internal medicine, Ascites, Fatty liver, and Estrogen receptor.
h-index
citations
872
works
9
NIH funding
primary concept
email

Recent publications

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine 2024cited by 3position: middledoi
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration
Journal of Clinical Medicine 2024cited by 2position: middledoi
Safety of direct-acting antivirals for Hepatitis C infection and direct oral anticoagulants co-administration: an Italian multicentric study
Digestive and Liver Disease 2024cited by 0position: middledoi
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine 2023cited by 123position: middledoi
Rare ATG7 genetic variants predispose patients to severe fatty liver disease
Journal of Hepatology 2022cited by 90position: lastdoi
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort
BMC Infectious Diseases 2021cited by 29position: middledoi
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
Journal of Hepatology 2020cited by 69position: middledoi
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)
Digestive and Liver Disease 2020cited by 45position: middledoi
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
The Lancet 2018cited by 511position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2021–2024) · 2 papers (2020–2024) · 1 papers (2024–2024) · 1 papers (2021–2021)Leonardo Baiocchi · Catholic University Our Lady of Good Counsel1 papers (2021–2021)Fabio Marra · Consorzio Roma Ricerche1 papers (2020–2020)Maurizia Rossana Brunetto · University of Pisa1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2021–2021)Valentina Cossiga · Federico II University Hospital1 papers (2021–2021) · 1 papers (2024–2024) · 1 papers (2021–2021)Giuseppina Brancaccio · Azienda Ospedale - Università Padova1 papers (2021–2021)Pietro Lampertico · Pitié-Salpêtrière Hospital1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2020–2020)Giovanni Addolorato · Institute for Health Metrics and Evaluation1 papers (2020–2020) · 1 papers (2021–2021)